However, a dose-dependent effective killing mediated by Vγ2Vδ2 T cells was observed with the addition of Vγ2 x PD-L1 irrespective of tumor cells’ origin, but not for Vγ2 x Null (Figure 6A). The gene discussed is CD274; the disease is neoplasm.